Improved Progression-Free Survival in Multiple Myeloma Patients Following Three-Drug Therapy With Autologous Stem Cell Transplant June 5, 2022 — Patients with multiple myeloma who have been ...

Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade ...

Multiple myeloma is a type of cancer where plasma ... induction therapy with the above or similar drugs. At times, a stem cell transplant may be recommended. A long term, follow-up study from ...

newly-diagnosed multiple myeloma (NDMM), there was no significant difference identified in the level of minimal residual disease (MRD) negativity with the use of single vs tandem autologous stem cell ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

Multiple Myeloma ... In India, myeloma represents around 1.8% of all cancers, with thousands diagnosed each year. Although ...

Revlimid is prescribed for adults with multiple myeloma. It may be taken by people with or without a past hematopoietic stem cell transplant (HSCT). (HSCT is a treatment for multiple myeloma in ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...